<i>TP53</i> ‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity-Reference-Cited by-同舟云学术

TP53 ‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity

Published:2022-11-17 Issue:2 Volume:129 Page:175-180
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Shallis Rory M.¹^ORCID,Daver Naval G.²^ORCID,Altman Jessica K.³,Hasserjian Robert P.⁴,Kantarjian Hagop M.²,Platzbecker Uwe⁵,Santini Valeria⁶,Wei Andrew H.⁷,Sallman David A.⁸,Zeidan Amer M.¹^ORCID

Affiliation:

1. Section of Hematology Department of Internal Medicine Yale School of Medicine Yale University New Haven Connecticut USA

2. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

3. Division of Hematology and Oncology Robert H. Lurie Comprehensive Cancer Northwestern University Feinberg School of Medicine Chicago Illinois USA

4. Department of Pathology Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA

5. Department of Hematology and Cellular Therapy Medical Clinic and Policlinic I Leipzig University Hospital Leipzig Germany

6. MDS Unit AOU Careggi University of Florence Florence Italy

7. Peter MacCallum Cancer Centre Royal Melbourne Hospital Walter and Eliza Hall Institute of Medical Research and University of Melbourne Melbourne Victoria Australia

8. Department of Malignant Hematology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34535

Reference40 articles.

1. Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal

2. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

3. Genomic Classification and Prognosis in Acute Myeloid Leukemia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TP53 Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates;American Society of Clinical Oncology Educational Book;2024-06

2. Evaluating targeted therapies in older patients with TP53 -mutated AML;Leukemia & Lymphoma;2024-04-22

3. p53 biology and reactivation for improved therapy in MDS and AML;Biomarker Research;2024-03-13

4. Acute Myeloid Leukemia Genomics: Impact on Care and Remaining Challenges;Clinical Chemistry;2024-01

5. Network-based clustering unveils interconnected landscapes of genomic and clinical features across myeloid malignancies;2023-10-27